Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 30:10:1178646917710668.
doi: 10.1177/1178646917710668. eCollection 2017.

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach

Giuseppe Corano Scheri  1 , Saeid Najafi Fard  1 , Ivan Schietroma  1 , Andrea Mastrangelo  1 , Claudia Pinacchio  1 , Noemi Giustini  1 , Sara Serafino  1 , Gabriella De Girolamo  1 , Eugenio Nelson Cavallari  1 , Maura Statzu  2 , Luca Laghi  3 , Annamaria Vullo  4 , Giancarlo Ceccarelli  5 , Vincenzo Vullo  1 , Gabriella d'Ettorre  5
Affiliations

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach

Giuseppe Corano Scheri et al. Int J Tryptophan Res. .

Abstract

Background: To date, no data are available regarding the effects of probiotics on the pathway of tryptophan/serotonin metabolism among human immunodeficiency virus (HIV) 1-infected individuals. Because a condition of dysbiosis might be responsible for the altered use of tryptophan described in this population, the aim of this study was to investigate the link between probiotic supplementation and serotonin levels in combined antiretroviral therapy-treated patients and the subsistence of an interplay with inflammation.

Methods: We conducted a pilot study that included 8 HIV-positive subjects. We collected blood and fecal samples before and after 6 months of probiotic supplementation, to measure the level of serotonin in serum and tryptophan in stool, the expression of CD38 and HLA-DR on peripheral CD4+ T lymphocytes (as immune activation markers), the expression of indoleamine 2,3-dioxygenase 1 messenger RNA (mRNA) and IFN-γ mRNA (as markers of tryptophan metabolism and systemic inflammation).

Results: After probiotic supplementation, we observed a significant increase in concentration of serum serotonin (P = .008) and a decreased level of tryptophan in plasma. Moreover, a significant reduction in CD38 and HLA-DR expression on the surface of peripheral CD4+ T cells (P = .008) and a reduced expression of indoleamine 2,3-dioxygenase 1 mRNA on peripheral blood mononuclear cells (P = .04) were observed.

Conclusions: Considering that this probiotic (Vivomixx® in EU; Visbiome® in USA) has an influence on tryptophan metabolism, larger studies on this topic are needed.

Keywords: HIV; IDO-1; IFN-γ; Probiotics; serotonin; tryptophan.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF CONFLICTING INTERESTS: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
IFN-γ mRNA expression in PBMC. IFN-γ mRNA expression before and after 6 months of probiotic supplementation in PBMC of combined antiretroviral therapy–treated HIV-1–positive patients with suppressed HIV-1 viremia (n = 6) P > .05. HIV-1 indicates human immunodeficiency virus 1; mRNA, messenger RNA; PBMC, peripheral blood mononuclear cell.
Figure 2
Figure 2
IDO-1 mRNA expression in PBMC. IDO-1 mRNA expression before and after 6 months of probiotic supplementation in PBMC of combined antiretroviral therapy–treated HIV-1–positive patients with suppressed HIV-1 viremia (n = 8) *P = .04. HIV-1 indicates human immunodeficiency virus 1; IDO-1, indoleamine 2,3-dioxygenase 1; mRNA, messenger RNA; PBMC, peripheral blood mononuclear cell.
Figure 3
Figure 3
Serum serotonin levels. Serum serotonin levels before and after 6 months of probiotic supplementation in combined antiretroviral therapy–treated HIV-1–positive patients with suppressed HIV-1 viremia (n = 8). *P = .008. HIV-1 indicates human immunodeficiency virus 1.
Figure 4
Figure 4
Possible modulation of tryptophan/serotonin pathway by probiotic supplementation.
See this image and copyright information in PMC

References

    1. MacDonald TT Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med. 1988;167:1341–1349. - PMC - PubMed
    1. Chahroudi A, Meeker T, Lawson B, Ratcliffe S, Else J, Silvestri G. Mother-to-infant transmission of simian immunodeficiency virus is rare in sooty mangabeys and is associated with low viremia. J Virol. 2011;85:5757–5763. - PMC - PubMed
    1. Xu H, Wang X, Veazey RS. Mucosal immunology of HIV infection. Immunol Rev. 2013;254:10–33. - PMC - PubMed
    1. Salas JT, Chang TL. Microbiome in human immunodeficiency virus infection. Clin Lab Med. 2014;34:733–745. - PMC - PubMed
    1. Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014;210:1248–1259. - PMC - PubMed

LinkOut - more resources